Figure 4
Figure 4. Reactivity of CLL rAbs with the native pUL32. Recombinant pUL32, pUL29, and untransfected 293FT cell sonicates were probed in parallel with 2-fold serial dilutions of CLL rAb CLL69B (stock solution, 10 μg/mL; A), CLL rAb CLL69D (stock solution, 10 μg/mL; B), CMV-specific immune serum (Se CMV+; C), and HSV-2–specific immune serum (Se HSV+; stock dilution of serum samples, 1:1500; D). Cell sonicates were harvested at 48 hours after transfection for EIA analysis with equal amounts of total protein used. Ab preparations were used at 1 to 10 μg/mL and were titrated to avoid saturation of binding sites. All experiments were done in duplicate and each Ab was tested against the 3 different protein preparations in parallel on the same EIA plate.

Reactivity of CLL rAbs with the native pUL32. Recombinant pUL32, pUL29, and untransfected 293FT cell sonicates were probed in parallel with 2-fold serial dilutions of CLL rAb CLL69B (stock solution, 10 μg/mL; A), CLL rAb CLL69D (stock solution, 10 μg/mL; B), CMV-specific immune serum (Se CMV+; C), and HSV-2–specific immune serum (Se HSV+; stock dilution of serum samples, 1:1500; D). Cell sonicates were harvested at 48 hours after transfection for EIA analysis with equal amounts of total protein used. Ab preparations were used at 1 to 10 μg/mL and were titrated to avoid saturation of binding sites. All experiments were done in duplicate and each Ab was tested against the 3 different protein preparations in parallel on the same EIA plate.

Close Modal

or Create an Account

Close Modal
Close Modal